Archives for 2025

Recognition at the British Association for Psychopharmacology summer meeting

3rd July 2025

British Association for Psychopharmacology (BAP) is a UK-based scientific society that promotes research and education in psychopharmacology—the study of how drugs affect mood, behaviour and mental processes. BAP supports both…

Parkinson’s drug effective in treating persistent depression

30th June 2025

A drug used for Parkinson’s disease has been shown to be effective in reducing the symptoms of difficult to treat depression, in a study led by the University of Oxford….

Mental health reimagined: Wearable tech and weight-loss drugs offer new hope

26th June 2025

Recent developments in psychiatry and neuroscience are shedding light on the potential of digital and pharmacological innovations to transform mental health care. Two new significant studies from the University of…

How do vaccines reduce the risk of dementia?

25th June 2025

A new study by the University of Oxford published in the journal npj Vaccines, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk in…

Chilean families to benefit from Oxford developed support for child anxiety

24th June 2025

The successful parent-led programme, developed with support from the NIHR Oxford Health Biomedical Research Centre (OH BRC) and the Applied Research Collaboration Oxford and Thames Valley (ARC OxTV), is being…

Mindfulness-based cognitive behavioural therapy found to help people with difficult-to-treat depression

16th June 2025

New research has found that a mindfulness-based psychological therapy that incorporates elements from cognitive behavioural therapy (CBT), may help to reduce symptoms in people with difficult-to-treat depression (DTD). The paper,…

Statins safe, but no antidepressant boost

12th June 2025

Statins deemed safe from a neuropsychiatric perspective but ineffective as antidepressants in at-risk adults, Oxford study finds. A landmark online trial published in Psychological Medicine and conducted at the University…

Study finds brain stimulation affects brain activity in teenagers with a neurological genetic disorder

5th June 2025

Researchers from the NIHR Mental Health Translational Research Collaboration (MH-TRC) Mission’s Children and Young People’s (CYP) Mental Health workstream have recently published a paper on brain stimulation in teenagers with Neurofibromatosis Type…

Westgate visitors learn about Oxford’s world-class research

30th May 2025

Researchers from Oxford’s two NIHR Biomedical Research Centres (BRC) took over the city’s Westgate Centre on Thursday 29 May for their annual Health Research Showcase. Hundreds of half-term visitors, including…

Last Haven: A citizen science project on nature, humanity and difficult choices

30th May 2025

What happens when the last known habitat for an endangered species stands in the way of vital human development? Last Haven, a study led by researchers at the University of…

New psychosis research network established for professionals

23rd May 2025

Recently, the NIHR Mental Health Translation Research Collaboration (MH-TRC) Mission Psychosis Network was launched to facilitate collaboration between psychosis researchers and clinicians in the UK. The network aims to facilitate…

The CADRE Project: Transformation in children’s healthcare research

21st May 2025

Recently, children and young people’s (CYP) mental health researchers from the Children and Adolescents Data Resource (CADRE) network came together to discuss progress in building a national data platform for CYP…

Oxford Brain Health Clinic: Pioneering research participation

20th May 2025

The UK government has set an ambitious target to have 10% of the population participating in research by 2025. This initiative aims to enhance public engagement in scientific research, ensuring…

Obesity drugs found to improve emotional wellbeing as well as physical health

19th May 2025

A major new meta-analysis has found that glucagon-like peptide 1 receptor agonists (GLP1- RAs) may also offer benefits for emotional wellbeing. A major new meta-analysis led by the Institute of…

Exciting academic opportunity for NMAHPs at Oxford Health BRC

16th May 2025

Oxford Health Biomedical Research Centre (OH BRC) is excited to announce an academic opportunity for Nurses, Midwives, and Allied Health Professionals (NMAHPs) connected with organisations in the Buckinghamshire, Oxfordshire and…

Raising awareness for Mental Health Awareness Week

12th May 2025

A Joint Effort by Oxford Health BRC and the University of Oxford Department of Psychiatry. Mental Health Awareness Week is an annual event that highlights the importance of mental well-being…

Join us at the Health Research Showcase 2025

6th May 2025

Come along to our Health Research Showcase at the Westgate Centre on Thursday 29 May from 10am to learn about the broad range of healthcare research taking place in Oxford…

New research shows afternoon could be the best time to use an inhaler

16th April 2025

A new asthma study has found that a dose of inhaled beclomethasone, known as Clenil Modulite® or the ‘brown’ steroid inhaler in the UK, could lead to better clinical outcomes…

New study highlights potential of GLP-1RAs in treating dementia

14th April 2025

A new paper in the Journal of Neurology, Neurosurgery & Psychiatry discusses how GLP-1RAs, drugs approved for diabetes and obesity, may play a role in the treatment of major neurocognitive…

Can digital tools help ease barriers to mental health trial recruitment?

8th April 2025

Researchers in the NIHR Mental Health Translational Research Collaboration (MH-TRC) Mental Health Mission (MHM) have contributed to a new report exploring the barriers to recruitment in mental health clinical trials…

Archives for 2025

Footer

Improving brain health: the future in mind

Follow us